Have a feature idea you'd love to see implemented? Let us know!

WVE Wave Life Sciences Ltd

Price (delayed)

$13.83

Market cap

$1.73B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.57

Enterprise value

$1.6B

Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using ...

Highlights
Wave Life Sciences's debt has decreased by 18% YoY and by 5% QoQ
The equity has plunged by 114% from the previous quarter but it has soared by 93% YoY
Wave Life Sciences's EPS has soared by 57% YoY but it has decreased by 10% from the previous quarter
The quick ratio fell by 27% YoY and by 17% QoQ
Wave Life Sciences's revenue has decreased by 2.1% QoQ

Key stats

What are the main financial stats of WVE
Market
Shares outstanding
124.74M
Market cap
$1.73B
Enterprise value
$1.6B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
16.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.48
Earnings
Revenue
$110.5M
EBIT
-$74.16M
EBITDA
-$65.37M
Free cash flow
-$129.62M
Per share
EPS
-$0.57
Free cash flow per share
-$1
Book value per share
-$0.03
Revenue per share
$0.85
TBVPS
$1.61
Balance sheet
Total assets
$208.82M
Total liabilities
$204.42M
Debt
$28.88M
Equity
-$3.48M
Working capital
-$1.05M
Liquidity
Debt to equity
-8.3
Current ratio
0.99
Quick ratio
0.9
Net debt/EBITDA
1.91
Margins
EBITDA margin
-59.2%
Gross margin
100%
Net margin
-66.5%
Operating margin
-75.7%
Efficiency
Return on assets
-32.1%
Return on equity
-1,400.9%
Return on invested capital
N/A
Return on capital employed
-207.8%
Return on sales
-67.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

WVE stock price

How has the Wave Life Sciences stock price performed over time
Intraday
0.88%
1 week
-4.29%
1 month
66.63%
1 year
160.94%
YTD
173.86%
QTD
68.66%

Financial performance

How have Wave Life Sciences's revenue and profit performed over time
Revenue
$110.5M
Gross profit
$110.5M
Operating income
-$83.69M
Net income
-$73.49M
Gross margin
100%
Net margin
-66.5%
Wave Life Sciences's net margin has surged by 81% YoY but it has decreased by 22% QoQ
The operating margin has soared by 80% YoY but it has contracted by 18% from the previous quarter
The company's net income rose by 44% YoY but it fell by 19% QoQ
The operating income has grown by 39% YoY but it has contracted by 16% from the previous quarter

Growth

What is Wave Life Sciences's growth rate over time

Valuation

What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
16.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.48
Wave Life Sciences's EPS has soared by 57% YoY but it has decreased by 10% from the previous quarter
The equity has plunged by 114% from the previous quarter but it has soared by 93% YoY
The P/S is 161% above the last 4 quarters average of 6.2 but 33% below the 5-year quarterly average of 24.1
Wave Life Sciences's revenue has decreased by 2.1% QoQ

Efficiency

How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has soared by 81% YoY but it has decreased by 22% from the previous quarter
WVE's return on assets is up by 50% year-on-year but it is down by 22% since the previous quarter

Dividends

What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for WVE.

Financial health

How did Wave Life Sciences financials performed over time
The total assets is 2.2% greater than the total liabilities
The quick ratio fell by 27% YoY and by 17% QoQ
WVE's current ratio is down by 25% year-on-year and by 17% since the previous quarter
The equity has plunged by 114% from the previous quarter but it has soared by 93% YoY
Wave Life Sciences's debt has decreased by 18% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.